跳到正文
原文
Moderna· @moderna_tx · X·· 13 天前AI 评分22
AI 导读

今日我们宣布,正在进行的 mRNA-2808 1/2 期研究的初步临床数据已入选第 68 届美国血液学会(ASH)年会口头报告,会议将于 2026 年 12 月 12–15 日在路易斯安那州新奥尔良举行。 了解更多:https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/moderna-announces-oral-presentation-of-mrna-2808-clinical-data-at-202-1245962 #ASH2026

正文

Today we announced that initial clinical data from our ongoing Phase 1/2 study of mRNA-2808 have been selected for oral presentation at the 68th American Society of Hematology (ASH) Annual Meeting, taking place December 12–15, 2026, in New Orleans, Louisiana.

Read more: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/moderna-announces-oral-presentation-of-mrna-2808-clinical-data-at-202-1245962

#ASH2026

来源:Moderna · x.com